Clinical Trial Update: Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update indicating the study of Z-360 in combination with gemcitabine for metastatic pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Z-360

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED